Last Week in Medicine
Wouldn't it be nice if someone reviewed all the latest internal medicine literature and distilled it into a brief podcast you could listen to on your way to work? Get updates from the New England Journal of Medicine, JAMA Network, Annals of Internal Medicine, Journal of Hospital Medicine, Journal of General Internal Medicine, Lancet and more.
Last Week in Medicine
Semaglutide for CVD in Diabetes, PAD, and MASH, Semaglutide vs Tirzepatide, Normal Saline vs Lactated Ringer's, Oxygen Targets for Intubated Patients, Platelet Transfusion Guidelines, Apixaban vs Rivaroxaban
Today we do a round-up of some of the recent semaglutide trials. Does semaglutide ever miss? But what about tirzepatide, which causes even more weight loss?
We also review two new critical care trials, FLUID and the UK-ROX, new platelet transfusion guidelines, and a new retrospective study of apixaban vs rivaroxaban vs warfarin.
Oral Semaglutide for Diabetes with Cardiovascular Disease or CKD (SOUL)
Semaglutide for Peripheral Artery Disease (STRIDE)
Semaglutide for MASH (ESSENCE)
Semaglutide vs Tirzepatide for Obesity (SURMOUNT-5)
Normal Saline vs Lactated Ringers (FLUID)
Conservative Oxygen Targets in Mechanically Ventilated Patients (UK-ROX)
Platelet Transfusion Guidelines
Apixaban vs Rivaroxaban vs Warfarin
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R